Skip to main content
Premium Trial:

Request an Annual Quote

NIH Stem Cell Registry Approves Genea Biocells' Stem Cell Lines

NEW YORK (GenomeWeb News) – The National Institutes of Health Stem Cell Registry has approved 52 human embryonic stem cell lines from Genea Biocells, the Australian company said this week.

The stem cell lines listed with the NIH Stem Cell Registry include 43 disease-specific lines covering 24 different genetic diseases, such as neurodegenerative ailments Huntington's disease, tuberous sclerosis, infantile neuroaxonal dystrophy, and others. They also include neuromuscular disorders, such as Charcot-Marie-Tooth disease, Becker muscular dystrophy, myotonic dystrophy, and facioscapulohumeral muscular dystrophy.

Cell lines expressing genes coding for genetic cancers, metabolic conditions, vascular diseases, and eye conditions also were approved, Sydney-based Genea Biocells said. The nine unaffected cell lines that were approved are from varied genetic backgrounds.

All cell lines are derived in compliance with international ethical and regulatory standards, the firm said.

Genea Biocells claims to have the world's largest private bank of pluripotent human embryonic stem cells with more than 100 individual lines that cover almost 30 genetic diseases. The firm said it is preparing applications to NIH for Genea Biocells' other cell lines.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.